Who are the key players in North America Genomics Market industry?

The top 5 key players in the North America Genomics Market are Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., QIAGEN, and Bio-Rad Laboratories. These companies innovate in genomics sequencing, technologies, and provide comprehensive solutions, significantly driving advances and adoption rates across clinical, research, and biotechnology domains.

What is the North America Genomics Market growth?

The North America Genomics Market is experiencing strong growth, driven by rising investments and advancements in sequencing technologies. For instance, Illumina's launch of cost-efficient sequencing platforms and expanded partnerships with clinical research organizations in 2023 accelerated market expansion.

Which segment accounted for the largest North America Genomics Market share?

The diagnostics segment accounted for the largest share of the North America Genomics Market. Driven by the increasing use of genomics in disease identification and personalized medicine, especially in cancer and rare disorders, diagnostic applications have seen rapid adoption in clinical settings across the region.

What are the factors driving the North America Genomics Market?

Major drivers include technological innovations, increased R&D investments, and a rising focus on precision medicine. For example, Thermo Fisher Scientific’s continuous development of high-throughput sequencing and data analysis tools accelerates genomic research and boosts market growth.

Which type accounted for the largest North America Genomics Market share?

Sequencing technologies accounted for the largest share in the North America Genomics Market. The demand for next-generation sequencing (NGS), supported by companies like Illumina and Thermo Fisher Scientific, continues to surge due to its pivotal role in genomics research, diagnostics, and drug discovery.

Home Healthcare

North America Genomics Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America Genomics Market
Brand: Bussiness Insights

North America Genomics Market: by Type (Products, Services), Application (Diagnostics, Drug Discovery & Development, Personalized Medicine, Agriculture & Animal Research, Others), Distribution Channels (Direct Sales, Distributors, Online, Retail Pharmacies, Hospital Pharmacies, Others), Technology (Sequencing, PCR, Microarray, CRISPR, NGS, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20248 | Author: Clara

RD TOC Segmentation Research Methodology Request For Free Sample

North America Genomics Market Outlook (2025-2035)

The North America Genomics Market is witnessing rapid expansion, powered by technological advancements and increasing adoption across healthcare, agriculture, and research domains. Genomics, the study of genomes, leverages various technologies such as sequencing, PCR, and CRISPR to enable deep genetic analysis, personalized medicine, and improved diagnostics. The integration of artificial intelligence and cloud-based platforms is further accelerating research and clinical adoption. The market's growth is amplified by rising demand for precision healthcare, expanding applications in drug discovery, and government initiatives supporting genomics infrastructure. With the U.S. at the forefront, leading players like Illumina, Thermo Fisher Scientific, and Agilent Technologies continue to innovate, shaping the competitive landscape. The market is projected to grow significantly, driven by key trends such as the shift towards personalized medicine and cost reductions in sequencing technology. However, reimbursement challenges and high capital costs remain notable restraints, alongside data privacy and regulatory hurdles.

Latest Market Dynamics

Key Drivers

Advancements in sequencing technology leading to reduced costs and increased accessibility, exemplified by

The North America genomics market, categorized by products and services, remains dominated by consumables, reflecting their critical role in routine genomic workflows and testing. Services are gaining traction as organizations increasingly outsource complex genomics analyses to specialized providers. Instruments and software solutions are pivotal in supporting high-throughput and advanced sequencing requirements, while kits and assays address growing needs in diagnostics and research. The enhanced demand for reliable consumables and a diverse suite of supporting services underpins continued market growth.

In 2025, diagnostics stands as the leading application within the North America genomics market, driven by increasing integration of genomics into clinical practice. Drug discovery and development follows closely, as pharmaceutical companies harness genomics to optimize R&D pipelines. Personalized medicine demonstrates significant momentum, with healthcare systems adopting tailored therapeutics based on genetic profiles. Agriculture and animal research, while a smaller segment, shows considerable growth potential due to advancements in crop and livestock genomics.

The North America genomics market has demonstrated robust revenue expansion from 2020 to 2035. Increasing demand for precise diagnostics and the proliferation of next-generation sequencing platforms have catalyzed sustained growth. Market revenue surged notably post-2025, aligned with policy incentives and growing clinical genomics adoption. As the integration of genomics accelerates across healthcare and agriculture, revenue is expected to reach unprecedented levels by 2035, reflecting continuous innovation, increased investment, and widespread accessibility.

Year-on-year growth rates in the North America genomics market reflect the sector’s dynamic response to evolving healthcare and research needs. Growth accelerated between 2024 and 2026, driven by technology breakthroughs and expanded clinical use. A stable yet steadily ascending trend is projected from 2027 onwards as genomics becomes increasingly mainstream. This YOY pattern highlights both the market’s maturing innovation cycle and the strategic investments made by key industry stakeholders.

The United States dominates the North America genomics market in 2025, attributed to its advanced healthcare ecosystem and ongoing investment in genomics research and commercialization. Canada holds a significant share, supported by government funding and burgeoning biotech hubs. Mexico, while a smaller player, is poised for rapid growth through international partnerships and agricultural genomics programs. This geographical distribution underscores the region’s strategic leadership in the global genomics landscape.

In 2025, Illumina leads the genomics market in North America, recognized for its innovation in sequencing technologies and expansive global footprint. Thermo Fisher Scientific and Agilent Technologies maintain strong positions through their diverse genomic solutions portfolios and robust distribution networks. Emerging players and specialty firms contribute to market competitiveness, but the market share remains largely consolidated among top industry leaders, ensuring technology advancements and reliable supply chains.

Academic and research institutions comprise the largest segment of genomics product and service buyers in North America for 2025, leveraging genomics for discovery and innovation. Hospitals and clinical labs are prioritizing genomics to enhance diagnostics and patient care, reflecting the rise of precision medicine. Pharmaceutical companies continue to expand their share, integrating genomics into R&D to streamline drug discovery, indicating a robust buyer ecosystem supporting sustained market growth.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	11100
Regions	United States, Canada, Mexico
Segments	Products, Services, Consumables, Instruments, Software, Kits & Assays, Diagnostics, Drug Discovery & Development, Personalized Medicine, Agriculture & Animal Research, Functional Genomics, Others
Players	Illumina, Thermo Fisher Scientific, Agilent Technologies, Qiagen, F. Hoffmann-La Roche, Bio-Rad Laboratories, Pacific Biosciences, GE Healthcare, Oxford Nanopore Technologies, Danaher Corporation, Eurofins Scientific, Myriad Genetics, BGI Genomics, 23andMe, Genomic Health

June 2024: Illumina launched the NovaSeq X Plus platform, offering 3x faster sequencing speeds.
July 2024: Thermo Fisher Scientific expanded CRISPR products with advanced gene-editing kits targeting rare diseases.
August 2024: Agilent Technologies announced AI-powered genomic data analysis features in its OpenLab software suite.
September 2024: Eurofins Scientific acquired a major clinical genomics laboratory to scale its diagnostic services.
October 2024: 23andMe rolled out a new comprehensive ancestry and health reporting product in North America.

About the Author

Clara

Senior Market Research Analyst

Clara is a Senior Market Research Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Clara brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Clara has helped organizations translate data into actionable growth strategies.

HealthcareMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

North America Genomics Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America Genomics Market Outlook (2025-2035)

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

North America Genomics Market Share by Type, 2025

North America Genomics Market Share by Applications, 2025

North America Genomics Market Revenue (USD Million), 2020-2035

North America Genomics Market Year-on-Year Growth (%), 2020-2035

North America Genomics Market Share by Region, 2025

North America Genomics Market Players Share, 2025

North America Genomics Market Buyer Share, 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports